시장보고서

상품코드

1654357

문합 장치 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Anastomosis Devices Market Size, Share & Trends Analysis Report By Product, By Application (Cardiovascular Surgery, Gastro-intestinal Surgery), By End Use, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2025년 01월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

문합 장치 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 문합장치 시장 규모는 2030년까지 58억 8천만 달러에 달할 것으로 예상되며 2025년부터 2030년까지 5.6%의 CAGR을 기록할 것으로 전망됩니다. 심혈관 및 위장 질환의 유병률 증가는 향후 몇 년간 문합 장치에 대한 수요를 촉진할 것으로 보입니다. WHO에 따르면 2019년 심혈관 질환(CVD)으로 사망한 사람은 약 1,790만 명으로 추정되며, 이는 전 세계 사망자의 32%에 해당합니다. 또한 이러한 사망의 85%가 뇌졸중과 심장마비로 인한 것이라고 합니다. 관상동맥 심장/동맥 질환(CHD/CAD)은 가장 흔한 유형의 심장 질환으로, 매년 약 805,000명의 미국인이 심장마비를 겪습니다. 이러한 생명을 위협하는 질병의 치료에는 수술이 매우 중요하기 때문에 이러한 수술에서 문합 장치의 채택이 증가하고 있습니다.

코로나19의 확산은 선택적 수술에 영향을 미쳤습니다. 코로나19로 인한 제한 조치로 인해 시술 횟수가 연기되었습니다. 현재 대부분의 국가에서 선택적 시술에 대한 제한이 강화되었습니다. 따라서 이러한 시술이 본격적으로 시작되면 문합 장치에 대한 수요가 증가할 것입니다. 또한 더 건강한 환자 결과에 대한 수요는 문합 기기의 첨단 기술 도입을 촉진하고 시장 성장을 촉진할 것입니다. 예를 들어, 2020년 10월, GI Windows Corp.는 존슨앤존슨 이노베이션 등의 투자를 유치한 시리즈 A-1 펀딩에서 1,640만 달러를 모금했습니다. 이 자금은 회사의 문합 기술 개발 및 임상 시험을 개선하기 위해 할당되었습니다.

문합 장치 시장 보고서 하이라이트

일회용 문합 장치는 2030년까지 계속해서 시장을 지배할 것이며, 2024년에는 전체 매출 점유율의 88.5%를 조금 넘는 점유율을 차지할 것입니다. 이러한 성장은 다양한 시장 참여업체의 광범위한 제품 제공에 기인할 수 있습니다.
재사용 가능한 제품은 생물의학적 폐기물을 줄여야 할 필요성이 증가함에 따라 예측 기간 동안 6.1%의 가장 빠른 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다.
응용 분야에 따라 심혈관 수술은 CHD의 유병률 증가와 전 세계적으로 증가하는 CABG 시술로 인해 2024 년 시장에서 가장 큰 점유율을 차지했습니다.
외래 진료 센터 및 클리닉 부문은 예측 기간 동안 5.7 %의 수익성있는 CAGR로 확장 될 것으로 예상됩니다. 만성 질환의 유병률 증가와 병원 재입원 사례로 인한 의료비 지출 증가로 외래 환자 센터의 확장이 촉진되었습니다.
북미는 잘 구조화 된 환급 정책, 대상 인구의 기반 확대, 많은 주요 업체들의 현지 존재로 인해 세계의 무대에서 선두를 달리고 있습니다.
아시아태평양은 노인 인구 증가, CVD 발생률 증가, 의료 부문의 급속한 발전, 가처분 소득 증가로 인해 예측 기간 동안 6.9 %의 수익성있는 CAGR을 기록 할 것으로 예상됩니다.

지역별 시장 점유율 분석(2024년, 2030년)
지역별 시장 대시보드
시장 규모, 예측 동향 분석(2018-2030년)
북미
- 국가별(2018-2030년)
- 미국
- 캐나다
- 멕시코
유럽
- 국가별(2018-2030년)
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 국가별(2018-2030년)
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 국가별(2018-2030년)
- 브라질
- 아르헨티나
중동 및 아프리카
- 국가별(2018-2030년)
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

참가자 개요
기업의 시장 포지셔닝 분석
기업 분류
전략 매핑
기업 프로파일, 상장 기업
- Medtronic
- MIZUHO Corporation
- Getinge
- Peters Surgical
- Baxter
- Medical Device Business Services, Inc.
- CarpoNovum AB
- Vascular Graft Solutions Ltd.
- Medline Industries, LP.
- Seger Surgical Solutions Ltd.

HBR 25.03.06

Anastomosis Devices Market Growth & Trends:

The global anastomosis devices market size is expected to reach USD 5.80 billion by 2030, registering a CAGR of 5.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of cardiovascular and gastrointestinal diseases is poised to propel the demand for anastomosis devices in the forthcoming years. According to the WHO, an estimated 17.9 million people died from Cardiovascular Diseases (CVD) in 2019, which represented 32% of all deaths in the world. It also states that 85% of these deaths are due to strokes and heart attacks. Coronary Heart/Artery Disease (CHD/CAD) is the most common type of heart disease and approximately 805,000 Americans have a heart attack each year. Surgery is crucial for the treatment of such life-threatening diseases, thereby increasing the adoption of anastomosis devices in these surgeries.

The outbreak of COVID-19 impacted elective procedures. Restrictions of COVID-19 resulted in postponements to the number of procedures performed. Presently most countries have elevated restrictions on elective procedures. Consequently, there would be lucrative demand for anastomosis devices as these procedures start with full force. Besides, demand for healthier patient outcomes will drive the introduction of advanced technologies in anastomosis devices and promotes market growth. For instance, in October 2020, GI Windows Corp. raised $16.4 million in a Series A-1 funding that involved investment from Johnson & Johnson Innovation and others. The funds are allotted to improve the development and clinical trials of the firm's anastomosis technology.

Anastomosis Devices Market Report Highlights:

Disposable anastomotic devices will continue to dominate the market until 2030, commanding just over 88.5% of the overall revenue share in 2024. The growth can be attributed to wide product offering by various market players
Reusable products are expected to grow at the fastest CAGR of 6.1% over the forecast period owing to the increasing need to reduce biomedical waste
Based on application, cardiovascular surgery held the largest share of the market in 2024 owing to the rising prevalence of CHD and the increasing number of CABG procedures around the globe
The ambulatory care centers & clinics segment is anticipated to expand at a lucrative CAGR of 5.7% during the forecast period. Increasing healthcare expenditure owing to the rising prevalence of chronic diseases and cases of hospital readmissions has encouraged the expansion of outpatient centers
North America was at the forefront in the global arena owing to the presence of well-structured reimbursement policies, widening base of the target population, and local presence of a large number of key players
Asia Pacific is expected to register a lucrative CAGR of 6.9% during the forecast period owing to the growing geriatric population, rising incidence of CVD, rapid developments in the healthcare sector, and increasing disposable income

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Anastomosis Devices Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Anastomosis Devices Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Disposable
- 4.4.1. Disposable Market, 2018 - 2030 (USD Million)
4.5. Reusable
- 4.5.1. Reusable Market, 2018 - 2030 (USD Million)

Chapter 5. Anastomosis Devices Market: Application Business Analysis

5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular Surgery
- 5.4.1. Cardiovascular Surgery Market, 2018 - 2030 (USD Million)
5.5. Gastro-intestinal Surgery
- 5.5.1. Gastro-intestinal Surgery Market, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Anastomosis Devices Market: End Use Business Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
6.5. Ambulatory Care Centers & Clinics
- 6.5.1. Ambulatory Care Centers & Clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Anastomosis Devices Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Anastomosis Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Competitive Insights
  - 7.4.4.4. Mexico Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Anastomosis Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Competitive Insights
  - 7.5.7.4. Norway Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Competitive Insights
  - 7.5.8.4. Denmark Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Sweden
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Competitive Insights
  - 7.5.9.4. Sweden Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Anastomosis Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. Japan Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. China Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. Competitive Insights
  - 7.6.4.4. India Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Competitive Insights
  - 7.6.5.4. South Korea Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. Competitive Insights
  - 7.6.6.4. Australia Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Competitive Insights
  - 7.6.7.4. Thailand Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Anastomosis Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA Anastomosis Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Competitive Insights
  - 7.8.3.4. Saudi Arabia Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. Competitive Insights
  - 7.8.4.4. UAE Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Competitive Insights
  - 7.8.5.4. Kuwait Anastomosis Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Medtronic
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. MIZUHO Corporation
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. Getinge
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. Peters Surgical
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. Baxter
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Medical Device Business Services, Inc.
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. CarpoNovum AB
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. Vascular Graft Solutions Ltd.
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. Medline Industries, LP.
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives
- 8.5.10. Seger Surgical Solutions Ltd.
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Strategic Initiatives

문합 장치 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Anastomosis Devices Market Size, Share & Trends Analysis Report By Product, By Application (Cardiovascular Surgery, Gastro-intestinal Surgery), By End Use, By Region, And Segment Forecasts, 2025 - 2030

문합 장치 시장의 성장과 동향

문합 장치 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 문합 장치 시장의 변수, 동향, 범위

제4장 문합 장치 시장 : 제품 비즈니스 분석

제5장 문합 장치 시장 : 용도 비즈니스 분석

제6장 문합 장치 시장 : 최종 용도 비즈니스 분석

제7장 문합 장치 시장 : 지역별, 추정 및 동향 분석